Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
---|
03/13/1991 | EP0416393A1 Peptidyl difluorodiol renin inhibitors |
03/13/1991 | EP0416373A2 Amino acid derivatives |
03/13/1991 | EP0416029A1 Procalcitonin peptides |
03/13/1991 | EP0403600A4 Deprotection of protected peptides |
03/13/1991 | EP0394326A4 Conformationally stabilized cell adhesion peptides |
03/13/1991 | EP0379534A4 Method of purifying cross-linked hemoglobin |
03/13/1991 | EP0185762B1 Cell-delivery agent |
03/12/1991 | WO1991004267A1 A method for the purification of transforming growth factor (tgf-) |
03/12/1991 | US4999422 Continuous method of refolding proteins |
03/12/1991 | US4999370 Compounds with a psychotropic action, agents containing them, and the use thereof for the treatment and prophylaxis of disorders of the central nervous system |
03/12/1991 | CA2066576A1 Method and apparatus for the production of tgf-beta and purified tgf-beta compositions |
03/12/1991 | CA2024661A1 Peptidase and isomerase inhibitors |
03/12/1991 | CA2023595A1 Chelating agents for forming complexes with radioactive isotopes, metal complexes thereof and use thereof in diagnosis and therapy |
03/12/1991 | CA1281500C2 Bifunctional chelating agents |
03/12/1991 | CA1281499C2 Bifunctional chelating agents |
03/12/1991 | CA1281330C2 Intermediates for the preparation of n-alkylated dipeptides and their esters |
03/08/1991 | CA2024782A1 High molecular weight protein/fatty acid condensation products which are very well tolerated by the skin and mucosa |
03/08/1991 | CA2024697A1 Protein having anticoagulant properties |
03/08/1991 | CA2005917A1 Method for activating polymeric carriers and compositions prepared therefrom for use in affinity chromatography |
03/07/1991 | WO1991002978A1 Immunoassay of glycosylated proteins employing antibody directed to reductively glycosylated n-terminal amino acids |
03/07/1991 | WO1991002796A1 Cystic fibrosis gene |
03/07/1991 | WO1991002790A1 Enzymes which participate in c-terminal amidation, and production and use thereof |
03/07/1991 | WO1991002789A1 Treatment of immobilized matrices with antimicrobial agents to remove pyrogen-producing organisms and pyrogens |
03/07/1991 | WO1991002753A1 Anticoagulant protein |
03/07/1991 | WO1991002714A1 Automated peptide design and synthesis |
03/07/1991 | WO1991002537A1 Synthetic peptides that enhance cell binding |
03/07/1991 | WO1990014844A3 Sugars as cleavable linkers for the delivery and release of agents in native form |
03/07/1991 | CA2039174A1 Enzyme participating in c-terminal amidation, and method of preparing same and use thereof |
03/07/1991 | CA2024701A1 Process for the purification of plasminogen activator inhibitor 2 (pai-2) |
03/06/1991 | EP0415902A1 Oxy- or thio-substituted fatty acid analogs for use in the treatment of retroviral infections |
03/06/1991 | EP0415801A1 Monoclonal antibodies against activated microglial cells |
03/06/1991 | EP0415557A2 Separation of anti-metal chelate antibodies |
03/06/1991 | EP0415331A2 Allyl esters and their application to the construction of solid phase systems for solid phase reactions |
03/06/1991 | EP0415219A1 ANF-Antagonist |
03/06/1991 | EP0414915A1 New superoxide dismutase |
03/06/1991 | EP0414807A1 Human mammary cell growth inhibitor and methods of production and use |
03/06/1991 | CA2024698A1 Peptidyl diflurodiol renin inhibitors |
03/06/1991 | CA2024598A1 Method for activating protein c |
03/05/1991 | WO1991003487A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
03/05/1991 | US4997915 Purification of pertussis toxins |
03/05/1991 | US4997914 Method for separating and purifying lactoferrin from milk by use of sulfuric ester |
03/05/1991 | US4997913 pH-sensitive immunoconjugates and methods for their use in tumor therapy |
03/05/1991 | CA2066449A1 Prodrug derivatives of thyrotropin-releasing hormone (trh) |
03/05/1991 | CA2024250A1 Method for purifying low molecular weight compounds of peptide of pseudo-peptide structure |
03/05/1991 | CA2023099A1 Amino acid derivatives |
03/05/1991 | CA1280987C Antibacterial composition |
03/05/1991 | CA1280972C Complex immunogen containing synthetic peptides |
03/02/1991 | CA2024489A1 Method of inhibiting virus |
03/02/1991 | CA2024053A1 Anf-antagonist |
02/27/1991 | EP0414632A2 Cyclosporin derivatives |
02/27/1991 | EP0414374A2 Novel antigens and methods for their preparation |
02/27/1991 | EP0413967A1 Novel antibiotic |
02/27/1991 | EP0413908A2 Soluble extracellular fragment of the human IFN-beta 2/IL-6 receptor, its preparation and pharmaceutical compositions containing it |
02/27/1991 | EP0413818A1 Process for producing a human neutrophil chemotactic factor polypeptide. |
02/27/1991 | CN1049505A Peptides having bradykinin-antagonistic action |
02/26/1991 | US4996358 Control, prevention rheumatic diseases |
02/26/1991 | US4996159 Purified polypeptides |
02/26/1991 | CA1280693C Purification of pertussis antigens |
02/24/1991 | WO1991002977A1 Wound healing preparations containing heparanase |
02/24/1991 | CA2065744A1 Wound healing preparations containing heparanase |
02/21/1991 | WO1991002058A1 Production of vascular endothelial cell growth factor |
02/21/1991 | WO1991002005A1 Natural human anti-gamma interferon antibodies detected and purified by synthetic peptides |
02/21/1991 | WO1991001976A1 Thioacylating reagents and intermediates, thiopeptides, and methods for preparing and using same |
02/21/1991 | WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
02/21/1991 | WO1991001744A2 Uses of interleukin-4 and method for purifying it |
02/21/1991 | DE4006436C1 Refining proteins from crude suspension or soln. - by warming with microwave energy to denature unwanted proteins, used for refining invertase from baker's yeast |
02/21/1991 | CA2064753A1 Uses of interleukin-4 and method for purifying it |
02/20/1991 | EP0413277A1 Peptide antagonists of bradykinin |
02/20/1991 | EP0413209A1 LHRH analogs |
02/20/1991 | EP0413024A1 Protein having activity of inhibiting inflammation-inducing phospholipase a2 |
02/20/1991 | CN1049353A Cyclic neurokinin a antagonists |
02/19/1991 | WO1991002755A1 Fibulin |
02/19/1991 | US4994605 Method of separating alpha-L-aspartyl-L-phenylalanine methyl ester through crystallization |
02/19/1991 | US4994556 Antitumor agents |
02/19/1991 | US4994555 Process for recovery of glycopeptidic antibiotics |
02/19/1991 | US4994554 Probursin |
02/19/1991 | CA2064818A1 Fibulin |
02/19/1991 | CA1280379C Peptides and compositions |
02/19/1991 | CA1280365C Radionuclide antibody coupling |
02/13/1991 | EP0412841A1 Human thrombomodulin derivatives |
02/13/1991 | EP0412542A2 Cyclic neurokinin antagonists |
02/13/1991 | EP0412508A1 Analogues of vasopressin, their preparation and pharmaceutical use |
02/13/1991 | EP0412466A2 Preparation of a stable factor VIII |
02/13/1991 | EP0412465A1 Process for correct biocatalytic chain folding of denaturated recombinant fusion proteins |
02/13/1991 | EP0412350A2 Renininhibitors, procedure for their preparation and use as medicaments |
02/13/1991 | EP0412105A1 Stem cell inhibitors |
02/13/1991 | CN1049164A Aminooligohydroxy derivatives for inhibiting renin and process for preparing same |
02/13/1991 | CN1049106A Stabilized fgf composition and production thereof |
02/12/1991 | WO1991001739A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
02/12/1991 | US4992531 Production of proteins in active forms |
02/12/1991 | US4992383 Method for protein and peptide sequencing using derivatized glass supports |
02/12/1991 | US4992369 Fermentation process for glycopeptide antibiotic |
02/12/1991 | US4992271 Formulation for lipophilic IL-2 proteins |
02/12/1991 | US4992178 Inorganic ultrafiltration of microfiltration membrane modified by a hydrophilic polymer, its preparation process and its use for the separation of proteins |
02/12/1991 | CA2064787A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
02/12/1991 | CA2022713A1 Human thrombomodulin derivatives |
02/12/1991 | CA2021880A1 Psycho-pharmacological peptides |
02/12/1991 | CA1280072C Antigens related to the aids virus glycoprotein envelope, especially precursors of this glycoprotein, methods for obtaining theses antigens and measures applied in these methods, applications of these antigens to the preparation of immunogen compositions or for the diagnosis of aids or related conditions |
02/09/1991 | CA2022816A1 Compounds |
02/07/1991 | WO1991001144A1 Labeled polypeptide derivatives |